ClinicalTrials.gg
Sign In

Cardiovascular Diseases clinical trials

The registry lists 5,368 studies for Cardiovascular Diseases across more than 10 countries. 939 are recruiting or about to start. 2,070 of them are mainly about Cardiovascular Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 251 narrower conditions too, such as Stroke: 69,176 studies, 14,990 open.

ClinicalTrials.gov finds 67,266 studies for Cardiovascular Diseases. How that becomes 5,367 here

This page counts the studies the registry files under Cardiovascular Diseases, and those it files under no condition that list Cardiovascular Diseasesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 67,266Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −59,033Filed under a narrower condition, counted on its own pageStroke 7,577 · Heart Failure 5,221 · Hypertension 5,016 · Coronary Artery Disease 4,199 · Multiple Myeloma 3,659 · Atrial Fibrillation 3,145 · 231 more
  3. −92List Cardiovascular Diseases as a condition, but the registry did not file them under itMost often written as “Cardiovascular Disease Risk Factors” (7), “Cardiovascular Disease Risk Factor” (7), and “Cardiovascular Disease Risk” (6). The registry filed 42 of them under no condition at all, and the others under other conditions only, most often Obesity (11) and Motor Activity (9).
  4. −2,774Match it another way318 name it in the title, 53 in a keyword, and 2,403 by a synonym or other text the search reads.
  5. 5,367The count on this page

Get an email when these change. Save the Cardiovascular Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
3,249
Recruiting
666
Status unknown
538
Active, not recruiting
306
Not yet recruiting
209
Terminated
199

Phase

Phase 3
368
Phase 2
338
Phase 4
314
Phase 1
212
Early Phase 1
29

Where

United States
1,715
Canada
413
United Kingdom
379
China
294
Germany
255
Netherlands
230

Who runs them

National Heart, Lung, and Blood Institute (NHLBI) (493) · Brigham and Women's Hospital (45) · VA Office of Research and Development (44) · Duke University (42) · AstraZeneca (39) · University of Toronto (39) · Penn State University (37) · University of Pennsylvania (36)

What is being tested here

Drugs under test in Cardiovascular Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Aspirin7740
Rivaroxaban7212
Semaglutide617
Colchicine5311
Omega-3 fatty acid3617
Metformin3115
Empagliflozin308
Inclisiran346
Atorvastatin2436
Fish Oils2111

Drug classes tested here SGLT2 inhibitors 9 open · NSAIDs 7 open · Factor Xa inhibitors 7 open · Statins 6 open · GLP-1 receptor agonists 6 open

Coming up

45phase 3 studies under way
309studies finish main data collection within a year7 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 666 Cardiovascular Diseases studies recruiting now, 389 (58%) set no upper age limit and 141 (21%) stop at 75 or younger. 76 (11%) take children under 18. 33 (5%) are for women only and 7 (1%) for men only; 174 (26%) take healthy volunteers.

Recruiting studies that take each age, of 666
AgeWomenMen
1066 (10%)65 (10%)
18462 (69%)449 (67%)
30525 (79%)507 (76%)
40582 (87%)559 (84%)
50607 (91%)588 (88%)
65607 (91%)590 (89%)
75553 (83%)542 (81%)
85470 (71%)461 (69%)

Across all 5,368 studies, recruiting or not: 30% stop at 75 or younger and 17% at 65; 18% take children; 6% are for women only and 9% for men only; 29% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cardiovascular Diseases studies take

Of 113 phase 4 interventional studies under Cardiovascular Diseases, half reached primary completion within 46 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 115 mo3–45 · 96 studies3 mo1–15 · 53 studies45 mo17–67 · 43 studies
Phase 1/240 mo34–62 · 20 studies——
Phase 228 mo16–59 · 84 studies—38 mo23–62 · 60 studies
Phase 357 mo34–83 · 82 studies48 mo29–79 · 42 studies57 mo41–95 · 40 studies
Phase 446 mo26–64 · 113 studies—46 mo28–76 · 107 studies
Interventional, no phase26 mo12–49 · 1,216 studies26 mo15–53 · 139 studies26 mo12–48 · 1,077 studies
Observational61 mo24–192 · 664 studies31 mo15–48 · 84 studies70 mo28–196 · 580 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting11

Show 6 more

Results posted3

Stopped1

Newly registered20

Show 15 more

Studies

Recruiting first, then most recently updated. Showing 50 of 5,368. Browse all 5,368 → or search them.